Osteopontin is a prognostic biomarker in non-small cell lung cancer.
about
Aberrant expression of osteopontin and E-cadherin indicates radiation resistance and poor prognosis for patients with cervical carcinomaPrognostic significance of osteopontin in patients with lung cancer: a meta-analysis.The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts.Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.Prognostic significance of osteopontin in patients with non-small cell lung cancer: results from a meta-analysis.Correlation between lung neoplasm and serum level of osteopontin: A meta-analysis.New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.Role of osteopontin in the pathophysiology of cancer.Osteopontin as a therapeutic target for cancer.Osteopontin: its potential role in cancer of children and young adults.Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.The role of osteopontin expression in melanoma progression.Association of osteopontin expression with the prognosis of glioma patient: a meta-analysis.Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.Runx3 and Cell Fate Decisions in Pancreas Cancer.SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling.Serum osteopontin in patients with lung cancer and chronic obstructive pulmonary disease: does the co-existence make the difference?
P2860
Q35009786-807A0216-11D3-44B2-BB81-FCCA01D74467Q35558111-A6F464E3-6F73-40C5-8C08-5D676A6A7DE1Q35863920-AF164EDB-BD99-46E8-A94D-2911C91A8B36Q36079101-71D2ACCF-C82D-44F5-955E-BD86F3E03186Q36182815-D60B039F-C217-4B62-AD34-36C868BA432CQ36824788-8D40489E-2873-4C11-B055-BFF8543F57D9Q37665446-FA921FFC-79BE-4610-A8F3-5268E945B16FQ38198463-2CFD5DAE-D63E-4BA6-9D54-7C929D1826ADQ38217758-DF83DCBA-D058-4F03-8874-652C7F26D394Q39192350-3DA71B88-1A52-4B77-A3CC-62A0A67D7458Q40704991-1241BBA0-0D12-4A18-90D1-79578B968D32Q40973252-B035B46F-BE54-4211-88FC-8EBDE48122C0Q45737032-B0AC3E1A-1D1F-4BD5-A140-DBC1E8EBDE81Q46874621-3FFB9B21-72F7-44F8-86DA-F992AE298083Q51097608-0A7927D3-7BDF-4B4F-A512-BE5E7AE1C460Q51734190-2F3195EB-C81E-49FB-81AE-0DDAEC57826CQ55002130-CE691D24-4F4E-4964-A0D0-CB5C17C72C4E
P2860
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@ast
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@en
type
label
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@ast
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@en
prefLabel
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@ast
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Osteopontin is a prognostic biomarker in non-small cell lung cancer.
@en
P2093
Ane Kongsgaard Rud
Ann Rita Halvorsen
Gisle Berge
Kjetil Boye
Marius Lund-Iversen
Miriam Oijordsbakken
Steinar K Solberg
P2860
P2888
P356
10.1186/1471-2407-13-540
P407
P577
2013-11-11T00:00:00Z
P5875
P6179
1009324168